The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than ever. During this webinar on International Clinical Trials Day, we will discuss how to decentralize your trials in order to keep them going during the COVID-19 pandemic. Decentralized clinical trials (DCTs) offer a more patient-centric approach in which fewer clinic visits are required and patient and caregiver burden are reduced. During this time, DCTs are critical to maintain patient safety, data quality and research continuity.
Featuring Craig Lipset, former Head of Clinical Innovation at Pfizer, Kai Langel, Director of Clinical Innovation at Janssen, Paul Bodfish, VP of Corporate Services at the Medical Research Network, and Derk Arts, MD, PhD, Founder and CEO of Castor. These experts will discuss the following topics:
- Issues faced by clinical researchers due to the COVID-19 pandemic
- The approach, benefits and challenges of conducting decentralized trials
- A guide to implementing remote enrollment, screening, eConsent and data capture
- How to engage with patients via ePRO, native diary apps and video calls
- How to combine data from eCRF, eCOA, ePRO, wearables and EHR data into one platform
Craig Lipset, Former Head of Clinical Innovation, Pfizer
Former Head of Clinical Innovation at Pfizer, Craig is an internationally-respected adviser, educator, and thought leader. Craig has received hall-of-fame recognition among PharmaVOICE’s Most Inspiring People In Life Science.Message Presenter
Kai Langel, Director of Clinical Innovation, Janssen
The Director of Clinical Innovation at Janssen, Kai brings global experience in development, delivery, and consultation of patient-centric solutions for clinical trials. An out-of-the-box thinker, Kai’s passion for developing innovative, workable solutions provides a unique viewpoint.Message Presenter
Paul Bodfish, VP of Corporate Services, Medical Research Network
As VP of Corporate Services at the Medical Research Network, Paul is responsible for overseeing Contracts, Vendor Management, Quality Management Systems and Technology & Data related activities. Paul also provides operational support for site and research nurses as part of his diverse duties.Message Presenter
Derk Arts, MD, PhD, Epidemiologist, Founder & CEO of Castor EDC
Derk Arts MD, PhD has over ten years of experience in medicine, research and technology. During his MD training, he observed that medical research is stuck in the 1980’s, not leveraging the power of data and technology but depending on aged standards and inefficient manual processes.
To solve these issues he founded Castor, a global healthtech company that enables researchers and manufacturers to maximize the impact of data through clinical trial automation and data reuse, while supporting a patient-centric, decentralized approach to research. Since 2012, Castor has delivered solutions to support more than 4,000 commercial and academic studies that cover a broad range of disease areas including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology.
Castor’s goal is to provide access to standardized data in real-time, enable the use of AI across standardized datasets, and accelerate the discovery of evidence that can help manage diseases and pandemics. For example, Castor joined the global fight against the Coronavirus by making its research data capture system available for free for all COVID-19 studies. As of May 1, Castor is supporting more than 180 COVID-19 studies across 15 countries, including one of the world’s largest randomized controlled trials on this disease.Message Presenter
Who Should Attend?
This webinar may be of interest to senior professionals within the medical device, biotech and pharma industries in the areas of:
- Clinical / Medical Affairs
- Clinical Research / Operations
- Research and Development
- Clinical Data Management
- Contract Research Organizations
- Product Management
What You Will Learn
In this webinar, attendees will learn about:
- How to prioritize patients in the COVID-19 era
- What technology is available to decentralize new and existing trials
- What opportunities do the updated regulations present for decentralization
- What types of studies and outcomes lend themselves to being conducted remotely
A global healthtech company, Castor enables manufacturers and research organizations to optimize clinical trials through the capture of high-quality clinical data that are reusable, thus maximizing their impact. Since 2012, Castor has delivered solutions to support over 4,000 studies in collaboration with medical device, biotech and academic organizations. Castor’s capabilities include Electronic Data Capture (EDC) to maximize productivity in clinical studies and integrate data from multiple sources, such as clinicians, patients, devices, wearables and EHR systems; electronic Patient Reported Outcome (ePRO) forms to administer surveys and collect clinical data into a centralized platform; eConsent to facilitate and automate patient enrollment processes; and many more cost-effective, custom solutions.